Elite Health Systems INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
Elite Health Systems Inc. has entered into a $525,000 subordinated note and warrant agreement with its CEO, Dr. Prasad Jeereddi, with provisions for additional investment.
Elite Health Systems Inc. announced its Board of Directors has authorized management to explore strategic alternatives, including potential capital raises, asset sales, mergers, or dispositions.
Elite Health Systems Inc. stockholders approved key proposals including director elections, an increase in authorized shares, a new equity plan, and the acquisition of Physician Support Systems, Inc.
Elite Health Systems Inc. announced an agreement to acquire Physician Support Systems, Inc. for 3,158,000 shares of common stock, a transaction involving its CEO and his daughter as major PSS stockholders.
Elite Health Systems' subsidiary, Elite Health Plan, Inc., has executed a contract with CMS to offer Medicare Advantage Plans, with member onboarding expected to begin in October 2025.
Elite Health Systems Inc. announced the appointment of Dr. Haranath Policherla as a non-executive director and Ken Minor as Chief Financial Officer, effective immediately.
Elite Health Systems Inc. has commenced a private placement to raise up to $5 million and entered a non-binding letter of intent to acquire Physician Support Systems, Inc., while its subsidiary Elite Health Plan received conditional CMS approval for its 2026 Medicare Advantage application.
Elite Health Systems Inc. has announced that its ticker symbol will change from USNU to EHSI, effective at market open on June 10, 2025, following FINRA approval.
8-K: Elite Health Systems Subsidiary Receives Conditional CMS Approval for 2026 Medicare Advantage Plan
Elite Health Systems Inc.'s wholly-owned subsidiary, Elite Health Plan, Inc., has received conditional approval from the Centers for Medicare and Medicaid Services for its Contract Year 2026 Medicare Advantage/Prescription Drug application, pending final bid approval and pre-implementation activities.
Elite Health Systems Inc.'s wholly owned subsidiary, Elite Health Plan, Inc., has been awarded a full-service health care service plan license in California, contingent on CMS approval, marking a significant step towards expanding its healthcare offerings.
Elite Health Systems has amended its private placement terms to increase the maximum raise to $5.5 million and issued 480,000 shares for compensation.
U.S. NeuroSurgical Holdings, Inc. has officially changed its name to Elite Health Systems Inc., effective September 30, 2024, and is in the process of launching a new corporate website.
U.S. NeuroSurgical Holdings has appointed a new CEO and Chairman, while also amending the terms of its private placement to raise up to $5 million.
U.S. NeuroSurgical Holdings has completed an initial closing of a private placement, raising $1 million to support the development of its subsidiary, Elite Health Plans.